TW200504186A - Cyanopyridone derivatives - Google Patents

Cyanopyridone derivatives

Info

Publication number
TW200504186A
TW200504186A TW093104311A TW93104311A TW200504186A TW 200504186 A TW200504186 A TW 200504186A TW 093104311 A TW093104311 A TW 093104311A TW 93104311 A TW93104311 A TW 93104311A TW 200504186 A TW200504186 A TW 200504186A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
polymers
cyanopyridone derivatives
cyanopyridone
derivatives
Prior art date
Application number
TW093104311A
Other languages
English (en)
Inventor
Louise Diane Farrand
Michael Heckmeier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of TW200504186A publication Critical patent/TW200504186A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3483—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a non-aromatic ring
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • C09K2323/02—Alignment layer characterised by chemical composition

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyridine Compounds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
TW093104311A 2003-02-22 2004-02-20 Cyanopyridone derivatives TW200504186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03003968 2003-02-22

Publications (1)

Publication Number Publication Date
TW200504186A true TW200504186A (en) 2005-02-01

Family

ID=32892857

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093104311A TW200504186A (en) 2003-02-22 2004-02-20 Cyanopyridone derivatives

Country Status (7)

Country Link
US (1) US7442475B2 (zh)
EP (1) EP1594842A1 (zh)
JP (1) JP2006523184A (zh)
KR (1) KR20050109505A (zh)
CN (1) CN1753873A (zh)
TW (1) TW200504186A (zh)
WO (1) WO2004074253A1 (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
TW200626139A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
WO2006034440A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
BRPI0515483A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
EP1814551A2 (en) 2004-09-20 2007-08-08 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
TW200626572A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
LU91146B1 (en) 2005-03-10 2006-09-11 Ipalco Bv Device for suppying preconditioned air to an aircraft on the ground
EP2540296A1 (en) 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
AU2009285584B2 (en) * 2008-08-29 2015-04-02 Treventis Corporation Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
US8257639B2 (en) * 2009-09-22 2012-09-04 Kent State University Method of making stimuli responsive liquid crystal-polymer composite fibers
US8168084B2 (en) 2009-12-18 2012-05-01 Vanderbilt University Polar nematic compounds
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
BR112016008378B1 (pt) 2013-10-14 2022-11-08 Eisai R&D Management Co., Ltd Compostos de quinolina seletivamente substituídos ou sal dos mesmos, e composição farmacêutica contendo os ditos compostos
WO2015057659A1 (en) 2013-10-14 2015-04-23 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
KR102392188B1 (ko) 2014-10-27 2022-04-28 삼성전자주식회사 편광 필름용 조성물, 편광 필름 및 표시 장치
KR20170097154A (ko) * 2014-12-19 2017-08-25 메르크 파텐트 게엠베하 광 변조 소자
CN108341771B (zh) * 2017-01-21 2021-05-11 浙江九洲药业股份有限公司 一种3-氰基-2,6-二羟基吡啶钠水合物的制备方法
CN109705343B (zh) * 2018-12-12 2020-11-06 上海交通大学 薁基共价三嗪骨架及其应用
CN112980225A (zh) * 2021-02-25 2021-06-18 张家港莱拓新材料科技有限公司 一种新型可聚合介晶混合物涂料及其应用
CN113292576B (zh) * 2021-06-08 2023-05-30 山西大学 一类基于三苯胺的光热小分子及其制备方法和应用
IL309666A (en) 2021-07-09 2024-02-01 Plexium Inc Aryl compounds and pharmaceutical preparations that modulate IKZF2

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175432B1 (da) 1984-10-30 2004-10-18 Otsuka Pharma Co Ltd Middel til forögelse af anticancervirkningen af anticancerforbindelser
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
US4684477A (en) 1985-03-06 1987-08-04 Chisso Corporation Pyridine derivatives and their use in liquid crystals
JPS61204168A (ja) * 1985-03-06 1986-09-10 Chisso Corp ピリジン誘導体
JPH0625119B2 (ja) * 1985-04-22 1994-04-06 チッソ株式会社 新規ピリジン誘導体
JPS61233672A (ja) * 1985-04-08 1986-10-17 Chisso Corp 正の誘電異方性を示すピリジン誘導体
JPH0232276B2 (ja) * 1985-07-18 1990-07-19 Chisso Corp Shinkipirijinjudotai
JPH0674248B2 (ja) * 1985-12-20 1994-09-21 チッソ株式会社 含窒素化合物
ES2058073T3 (es) * 1986-04-30 1994-11-01 Otsuka Pharma Co Ltd Derivados de 5-fluorouracilo.
JPH0688996B2 (ja) * 1986-07-24 1994-11-09 大塚製薬株式会社 ５−フルオロウラシル誘導体
JPS63201127A (ja) * 1987-02-17 1988-08-19 Otsuka Pharmaceut Co Ltd ５−フルオロウラシル誘導体を含有する制癌剤
JPH0749422B2 (ja) * 1986-12-25 1995-05-31 大塚製薬株式会社 ５−フルオロ−５，６−ジヒドロウラシル誘導体
WO1988007992A1 (en) 1987-04-07 1988-10-20 Pavljuchenko Assya I Liquid-crystal derivatives of 2,5-disubstituted pyridine as components of liquid-crystal material, and a liquid-crystal material
JPH02500274A (ja) * 1987-12-30 1990-02-01 パフルユチェンコ，アススヤ　イオシフォフナ 液晶材料の成分としての２，５‐二置換ピリジンの液晶誘導体および液晶材料
JP2700263B2 (ja) * 1988-12-16 1998-01-19 大塚製薬株式会社 ５―フルオロウラシル誘導体の製造法
JPH04288058A (ja) * 1990-07-11 1992-10-13 Fuji Photo Film Co Ltd フェニルピリジン化合物及びこれを含有する液晶組成物
JPH04217665A (ja) 1990-10-26 1992-08-07 Fuji Photo Film Co Ltd 分岐を有するフェニルピリジン化合物及びこれを含有する液晶組成物
JP3060331B2 (ja) * 1991-07-18 2000-07-10 コニカ株式会社 カラーフィルターアレイ素子
JPH0551536A (ja) * 1991-08-26 1993-03-02 Mitsubishi Kasei Corp パーフルオロアルキル基含有アゾ系色素
US5578419A (en) * 1991-12-12 1996-11-26 Mitsui Toatsu Chemicals, Incorporated Dyes for color filters, and photosensitive resist resin composition containing the same
JPH07207169A (ja) * 1994-01-12 1995-08-08 Mitsui Toatsu Chem Inc 偏光フィルム用アゾ系色素及びこれを用いた偏光フィルム
GB9922136D0 (en) * 1999-09-20 1999-11-17 Avecia Ltd Compounds, compositions and use
US6664025B2 (en) * 2002-02-12 2003-12-16 Kodak Polychrome Graphics Llc Visible radiation sensitive composition

Also Published As

Publication number Publication date
CN1753873A (zh) 2006-03-29
JP2006523184A (ja) 2006-10-12
EP1594842A1 (en) 2005-11-16
US20060165916A1 (en) 2006-07-27
KR20050109505A (ko) 2005-11-21
WO2004074253A1 (en) 2004-09-02
US7442475B2 (en) 2008-10-28

Similar Documents

Publication Publication Date Title
TW200504186A (en) Cyanopyridone derivatives
WO2004065523A8 (en) Ionic mesogenic compounds
ATE385251T1 (de) Substituierte anthracene
TW200638136A (en) Liquid crystal display device and electronic apparatus
AU2003202156A1 (en) Circuit for generating driving voltages and liquid crystal device using the same
TW566564U (en) Back light module and liquid crystal display using the same
JP2009541881A5 (zh)
TW200701148A (en) Liquid crystal display and driving method thereof
DE69923480D1 (de) Persönliche anzeigevorrichtung mit sichtverfolgung
AU2003212659A1 (en) Backlight assembly using the same and liquid crystal display device
TW200513717A (en) Liquid crystal display device
EP1850155A4 (en) HOMÖOTROPICALLY ORIENTED LIQUID CRYSTAL FILM, OPTICAL FILM THEREFOR AND PICTURE DISPLAY
TW200628899A (en) Liquid crystal display and electronic apparatus
ATE517165T1 (de) Fluorenderivate
AU2003214699A1 (en) Liquid crystal display device
ATE531780T1 (de) Kalamitische mesogene verbindungen
EP1855128A4 (en) PHOTODIFFUSION FILM, PLANAR LIGHT SOURCE ELEMENT THEREFOR AND LIQUID CRYSTAL DISPLAY EQUIPMENT
AU2003202783A1 (en) Electrophoretic display device and driving means for restoring the brightness level
ATE391159T1 (de) Polymerisierbare mesogene cyclohexylphenylderivate
TW200720267A (en) Chiral compounds
AU2003245077A1 (en) Back light assembly and liquid crystal display device having the same
TW200708863A (en) Liquid crystal orientation agent and liquid crystal display device
AU2003272062A1 (en) Electro-optical circuitry having integrated connector and methods for the production thereof
TW200712618A (en) Liquid crystal display device
WO2008077465A3 (en) Polymers comprising fused selenophene